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Abstract
The exon junction complex (EJC) is an RNA binding complex comprised of the core compo-
nents Magoh, Rbm8a, and Eif4a3. Human mutations in EJC components cause neurodeve-
lopmental pathologies. Further, mice heterozygous for eitherMagoh or Rbm8a exhibit
aberrant neurogenesis and microcephaly. Yet despite the requirement of these genes for
neurodevelopment, the pathogenic mechanisms linking EJC dysfunction to microcephaly
remain poorly understood. Here we employ mouse genetics, transcriptomic and proteomic
analyses to demonstrate that haploinsufficiency for each of the 3 core EJC components
causes microcephaly via converging regulation of p53 signaling. Using a new conditional
allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and
microcephaly ofMagoh and Rbm8amutant mice. Transcriptomic and proteomic analyses
of embryonic brains at the onset of neurogenesis identifies common pathways altered in
each of the 3 EJC mutants, including ribosome, proteasome, and p53 signaling compo-
nents. We further demonstrate all 3 mutants exhibit defective splicing of RNA regulatory
proteins, implying an EJC dependent RNA regulatory network that fine-tunes gene expres-
sion. Finally, we show that genetic ablation of one downstream pathway, p53, significantly
rescues microcephaly of all 3 EJC mutants. This implicates p53 activation as a major node
of neurodevelopmental pathogenesis following EJC impairment. Altogether our study
reveals new mechanisms to help explain how EJC mutations influence neurogenesis and
underlie neurodevelopmental disease.
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Author Summary
The mammalian neocortex is the brain structure responsible for higher cognition, abstract
thought, and language. One process critical for brain development is neurogenesis, in
which neural stem cell populations generate neurons. Alterations in neurogenesis can lead
to neurodevelopmental disorders affecting brain size and function, such as microcephaly,
in which the brain is significantly smaller than normal. Therefore, understanding the
genes and processes controlling normal brain development is of strong clinical relevance.
Here we studied proteins of the RNA binding exon junction complex, which are strongly
implicated in several neurodevelopmental pathologies, but whose functions in brain devel-
opment remain largely unknown. Using mouse models, we find that reduced levels of any
of three essential proteins of this complex results in altered embryonic neurogenesis and
microcephaly. We demonstrate that mutant mice show common alterations in p53 activa-
tion, expression of ribosomal components and splice variants for RNA processing factors.
Interestingly we find that genetic suppression of p53 significantly rescues microcephaly in
mutant mice. Given that patients harboring mutations in exon junction complex compo-
nents present with neurodevelopmental deficits, our findings highlight molecular path-
ways which could underlie disease pathogenesis.
Introduction
Proper function of the cerebral cortex, our brain structure responsible for higher cognitive
functions, relies upon embryonic neurogenesis. During neurogenesis, neural stem cells (NSCs)
generate excitatory neurons [1,2]. In mice the onset of neurogenesis is embryonic day (E) 10.5,
when NSCs consist of neuroepithelial cells that primarily undergo self-renewal divisions. As
development proceeds, neuroepithelial cells are replaced by radial glial cells that generate neu-
rons either directly, or indirectly via new NSCs and intermediate progenitors (IPs) (Fig 1A) [3–
5]. Defective neurogenesis impacts neuron production and can cause neurodevelopmental dis-
orders such as microcephaly, in which brain size is severely reduced. To elucidate causes for
such diseases requires a comprehensive understanding of how NSCs mediate proper brain
development.
One level of control increasingly implicated in NSC function and disease is post-transcrip-
tional regulation [6–8]. In particular, a set of RNA binding proteins associated with develop-
mental pathologies of the cerebral cortex is the exon junction complex (EJC). The core EJC,
composed of Rbm8a (Y14), Magoh, and Eif4a3 (Ddx48), influences mRNA splicing, transla-
tion, mRNA localization, and nonsense mediated decay (NMD), via direct interactions with
both RNA and auxiliary proteins in the nucleus and cytoplasm [9–15]. Copy number variations
of RBM8A, EIF4A3, and peripheral EJC components, are each strongly associated with neuro-
developmental phenotypes [16–18]. Moreover RBM8A and EIF4A3mutations cause TAR syn-
drome and Richieri-Costa-Pereira syndrome, respectively, both of which are associated with
neurological deficits [19–22]. While altered EJC levels are significantly linked to neurodevelop-
mental diseases, the pathogenic mechanisms by which EJC impairment causes these disorders
are largely unknown.
Recent studies from our lab have helped shed light on this question, with the discoveries
that haploinsufficiency for eitherMagoh or Rbm8a, disrupts mouse cortical development. In
these mouse models, both NSCs and IPs are depleted, neurons are ectopic, and there is massive
apoptosis of neurons and progenitors, all leading to severe microcephaly [23–26]. We recently
discovered that inMagohmutants these neurogenesis phenotypes may be due in part to
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prolonged mitosis of NSCs [26]. Moreover, we identified Lis1 as one relevant Magoh down-
stream target during neurogenesis [23]. While these studies showMagoh and Rbm8a are essen-
tial for corticogenesis, it remains unknown if impairment of the third major EJC constituent,
Eif4a3, causes microcephaly. Additionally, if all EJC components are required in the developing
brain, it is unclear whether they function via common regulatory pathways. This information
is critical to understand how EJC genes regulate brain development.
In this study we examined mice haploinsufficient forMagoh, Rbm8a, or Eif4a3, to expose
mechanisms by which EJC dysfunction impacts cortical development. First, we generated a
NSC-specific conditional Eif4a3mouse model to demonstrate that Eif4a3 haploinsufficiency
phenocopies the aberrant neurogenesis and microcephaly seen in Rbm8a andMagohmutants.
We then utilized transcriptomic and proteomic analyses to uncover common genetic pathways
controlled by all 3 EJC components at the onset of neurogenesis. These include expression
of factors associated with the ribosome, proteasome, and p53 signaling pathway. All 3 EJC
mutants showed splicing alterations in RNA processing factors, implicating the EJC in regulat-
ing a network of RNA metabolism factors. Finally, we focus on one of these downstream path-
ways, p53, and show that p53 ablation significantly rescues microcephaly of all 3 EJC mutants.
Altogether our study reveals novel mechanisms to help explain how EJC deficiency disrupts
Fig 1. EJC components are co-expressed in neurogenesis. (A) Schematic of embryonic neurogenesis of the dorsal telencephalon. NSC,
neural stem cell; IP, intermediate progenitor. (B) Two main questions posed in this study. 1. Does Eif4a3 haploinsufficiency cause
microcephaly? 2. Do EJC components regulate common pathways during neurogenesis? (C) qPCR ofMagoh, Eif4a3, and Rbm8amRNA
levels in developing neocortices of indicated ages. qPCR was performed using a standard curve, withMagoh relative expression at E10.5
set to 1.0, and all expression levels normalized toGapdh. (D-I) Immunofluorescence of E10.5 dorsal neocortices for Hoechst (blue), Magoh
(D, E), Rbm8a (F, G), and Eif4a3 (H, I). (E, G, I) are high magnification images of D, F, H, respectively. Student’s t test, Error bars, S.D., **,
p<0.01, ns = not significant. n = 3 biological replicates each age. Scale bars, D, F, H; 50 μm; E, G, I, 25 μm.
doi:10.1371/journal.pgen.1006282.g001
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neurogenesis, implicating elevated p53 signaling in the etiology of EJC-mediated neurodeve-
lopmental pathologies.
Results
Eif4a3 haploinsufficiency causes aberrant neurogenesis and
microcephaly
We previously showed that NSC-specific haploinsufficiency for eitherMagoh or Rbm8a causes
microcephaly in mice [23–25]. To understand whether common mechanisms contribute to
microcephaly following depletion of EJC core components, we first sought to address the role
of the third core EJC component, Eif4a3, in brain development (Fig 1B). We examined the
expression profile of Eif4a3 relative toMagoh and Rbm8a at early stages of cortical develop-
ment. RT-qPCR showed thatMagoh, Eif4a3, and Rbm8a are expressed in the developing neo-
cortex and show parallel increases in expression as neurogenesis proceeds (Fig 1C). In situ
hybridization revealed enriched Eif4a3 expression in the proliferative ventricular and sub-ven-
tricular zones of the E14.5 neocortex, where NSCs reside, in a similar pattern to Rbm8a and
Magoh [23,24,27] (S1A Fig). Immunostaining showed that at the onset of neurogenesis
(E10.5), EIF4A3 protein is expressed at detectable levels and is primarily localized within the
nucleus, similar to MAGOH and RBM8A (Fig 1D–1I). Together, these analyses indicate that
Eif4a3,Magoh and Rbm8a are co-expressed spatially and temporally in the developing mouse
neocortex.
We generated a conditional mouse carrying a floxed allele of Eif4a3 (Eif4a3lox/+) to assess
the phenotype of Eif4a3 deficiency in the developing brain (Fig 2A). Eif4a3lox/+ mice were
crossed to Emx1-Cre, which drives Cre expression in NSCs of the dorsal neocortex beginning
at E9.5 [28,29] (cre.jax.org). Genotyping of genomic DNA from Emx1-Cre;Eif4a3lox/+ mice
confirmed the presence of predicted bands for both wildtype and lox alleles (S1B Fig). Follow-
ing Cre recombination, exon 2 is excised to generate a transcript predicted to undergo NMD-
mediated degradation. Consistent with this, Eif4a3mRNA and protein were reduced by about
50% in Emx1-Cre;Eif4a3lox/+ neocortices (Fig 2B and 2C). These data demonstrate Eif4a3 can
be efficiently depleted in the conditional haploinsufficient mouse model.
We next analyzed the impact of Eif4a3 haploinsufficiency upon neurogenesis. At E12.5,
Emx1-Cre;Eif4a3lox/+ cortices were markedly smaller at a whole mount level (Fig 2D and 2E)
and 30% thinner when compared to control (Emx1-Cre) littermates (Fig 2F). PAX6-positive
NSCs were significantly reduced in density in Emx1-Cre;Eif4a3lox/+ neocortices compared to
control, an observation corroborated by western analysis (Fig 2G, 2I, 2K and S1C and S1D
Fig). The depletion of NSCs was associated with a concomitant increased thickness of the
TUJ1-positive neuronal layer (Fig 2H and 2J). These findings, smaller brain size, NSC deple-
tion, and excessive neurons, demonstrate that Eif4a3 haploinsufficiency phenocopies Emx1-
Cre;Rbm8alox/+ and Emx1-Cre;Magohlox/+ neocortices [23,24]. We also previously showed that
MagohMos2/+ germline mutant and Emx1-Cre;Rbm8alox/+ NSCs exhibit significant mitotic
defects [23,24,26]. Quantification of mitotic index using phospho-histone 3 (PH3) staining
revealed increased mitotic index of E11.5 Emx1-Cre;Eif4a3lox/+ neocortices compared to con-
trol (Fig 2L–2N). Extensive apoptosis as evidenced by cleaved-caspase3 (CC3), is also associ-
ated withMagoh and Rbm8a haploinsufficient brains [23,24]. Similarly, we noted extensive
apoptosis in Emx1-Cre;Eif4a3lox/+ neocortices (Fig 2O and 2P). Apoptosis was present in both
neurons and NSCs throughout the dorsal cortex, similar toMagoh and Rbm8amutants (Fig
2Q–2T). These early neurogenic phenotypes impacted brain structure. At E14.5, the dorsal tel-
encephalon was largely absent in Eif4a3 haploinsufficient brains (Fig 2U and 2V). Of the
remaining dorsal telencephalon tissue found adjacent to the pallial-subpallial boundary, the
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Fig 2. Eif4a3 is required for embryonic neurogenesis and brain size. (A) Top, Eif4a3 genomic mouse locus. Middle, targeted allele with 2 loxp sites
(black arrowheads), Neo cassette, and 2 FRT sites (white arrowheads). Genotyping primers are indicated. Bottom, the conditional allele following FLP-
and Cre-mediated recombination. (B) qPCR quantification of Eif4a3mRNA levels in E10.5 neocortices, following normalization usingGapdh. Eif4a3
mRNA level of Emx1-Cre samples was set to 1.0. (C) Quantification of Eif4a3 protein levels in E11.5 dorsal cortices by densitometry of western blots,
following normalization with α-Tubulin for loading. (D,E) Whole mount E12.5 Emx1-Cre and Emx1-Cre;Eif4a3lox/+ brains. Note the forebrain (dotted lines)
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cortex was extremely thinned and neurons were disorganized (Fig 2W and 2X). These pheno-
types are highly similar to Emx1-Cre;Rbm8alox/+ brains [24].
Surprisingly, despite the prevalent disruption of the developing neocortex, Eif4a3, Rbm8a,
andMagoh conditional mutant mice survive into adulthood [24,25]. We evaluated postnatal
(P) brain sizes of each EJC mutant. Comparison of P12 whole mount brains demonstrated sig-
nificant reductions in all 3 EJC mutants (Fig 3A–3E). Both Eif4a3 and Rbm8a haploinsuffi-
ciency caused severe microcephaly, with an average 70% reduction in cortical area of whole
mount brains [24] (Fig 3E). The microcephaly phenotype of Rbm8a and Eif4a3mutant mice
was significantly worse thanMagoh haploinsufficient mice, which exhibited a 40% reduction
[24,25]. This phenotypic difference may be due to redundant expression of a secondMagoh
homolog, whereas the other EJC components do not have identifiable homologs [30]. Together
with our previous studies, these analyses indicate that Eif4a3, Magoh, and Rbm8a each control
similar aspects of neurogenesis (NSC proliferation, number and apoptosis), and ultimately
brain size.
Transcriptome analysis of EJC mutants reveals alterations in expression
levels of ribosomal, proteasome, and p53 signaling components
Given the overlapping expression patterns, common neurogenesis phenotypes, and vast litera-
ture connecting Magoh, Rbm8a, and Eif4a3, we hypothesized that these EJC components work
is noticeably smaller in the Eif4a3mutant. (F) Quantification of cortical thickness of E12.5 Emx1-Cre and Emx1-Cre;Eif4a3lox/+ dorsal neocortices. (G-J) 4
different coronal sections from E12.5 Emx1-Cre (G,H) and Emx1-Cre;Eif4a3lox/+ (I,J) neocortices stained for Hoechst (blue), Pax6 (green, G,I) or Tuj1
(green, H,J). (K) Density of Pax6+ cells within 200 μmwide radial columns spanning the E12.5 cortices of indicated genotypes. (L, M) Images of E11.5
Emx1-Cre (L) or Emx1-Cre;Eif4a3lox/+ (M) cortices stained for PH3 (green). (N) Graph depicting percentage of all cells which are PH3-positive for
indicated genotypes at E11.5. (O-T) E12.5 coronal sections from Emx1-Cre (O) and Emx1-Cre;Eif4a3lox/+ brains (P-T) stained for Hoechst (blue), CC3
(red), Pax6 (green, Q, S), and Tuj1 (green, R,T). S and T are high-magnification views of Q and R, respectively, as indicated. Arrowheads depict cells co-
labeled for apoptotic and cell fate markers. (U-X) Coronal sections of E14.5 Emx1-Cre (U,W) and Emx1-Cre;Eif4a3lox/+ (V,X) cortices stained for Hoechst
(white or blue) and Tuj1 (green). W and X are high-magnification images of U and V, respectively as indicated. Red brackets denote cortical thickness.
Vent, ventricle. Student’s t test, *, p<0.05, ***, p<0.001. Error bars, S.D. n = 3 biological replicates each. Scale bars, D, E, 1 mm; G-J, L,M,O-R, W, X,
50 μm; S,T, 20 μm; U,V, 200 μm.
doi:10.1371/journal.pgen.1006282.g002
Fig 3. Haploinsufficiency of EJC components causesmicrocephaly. (A-D) Images of whole mount brains at P12 from indicated genotypes. Dotted
lines denote dorsal cortex. (E) Quantification of relative dorsal cortical area in P12 brains of indicated genotypes. The area of Emx1-Cre brains was set
to 1.0. ANOVA with Tukey posthoc, ***, p<0.001, Error bars, S.D. n = 3–4 biological replicates, Scale bar, A-D, 2 mm.
doi:10.1371/journal.pgen.1006282.g003
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together to influence cortical development. To test this, we aimed to identify molecular changes
associated with early neurogenesis in each of the three EJC mutants. We performed transcrip-
tome profiling of E10.5 neocortices from the following genotypes: Emx1-Cre, Emx1-Cre;
Rbm8alox/+, Emx1-Cre;Magohlox/+, and Emx1-Cre;Eif4a3lox/+ (n = 3 biological replicates each)
(Fig 4A). We focused on E10.5 for several reasons. This stage marks the beginning of neurogen-
esis when the neocortex is composed primarily of self-renewing neuroepithelial NSCs [4].
Moreover, it is just prior to the onset of severe defects in EJC mutants, and a stage when all 3
genes are reduced in their respective mutants, as evidenced by RT-qPCR of the RNA-sequenc-
ing samples (Fig 4B).
We examined global RNA changes in the 3 mutants relative to the control and to each
other. Amongst the 18,465 detectable coding and non-coding transcripts expressed in the
E10.5 control cortex, 2.9% were altered in Emx1-Cre;Rbm8alox/+, 0.9% were altered in Emx1-
Cre;Eif4a3lox/+, and 0.4% were altered in Emx1-Cre;Magohlox/+ (FDR, q<0.05) (S1 Table).
Hierarchical clustering of these significantly altered transcripts revealed segregation of control
and mutant biological replicates for all 3 EJC mutants, as evidenced in heat maps (Fig 4C).
Equivalent proportions of transcripts were upregulated and downregulated within individual
EJC mutants (Fig 4D, S1 Table). We validated expression for several differentially expressed
transcripts, Tbr2, Ngn2, NeuroD6, and Gtse1, using RT-qPCR, which showed similar trends
to RNA-seq data (Fig 4E and 4F, S2B Fig). Despite the fact that the EJC binds a large fraction
of expressed transcripts in immortalized cells [31–33], these experiments suggest EJC haploin-
sufficiency does not broadly impair transcript levels of E10.5 neocortices. This observation ech-
oes previous microarray studies of germlineMagohMos2/+ mutant brains [23], Eif4a3 silenced
Xenopus [34], and EJC Drosophilamutants [35].
We next assessed the extent to which transcripts overlapped amongst the EJC mutants,
focusing only on the fraction of alterations which were highly significant (q<0.05). We noted
extensive overlap in pairwise comparisons between individual mutants (S2A Fig). Of the 70
Magoh dependent transcripts, 87% were altered in Rbm8amutants and 46% were altered in
Eif4a3mutants. Of the 172 transcripts altered in Eif4a3mutants, 19% overlapped withMagoh
mutants and 46% overlapped with Rbm8amutants. Fisher’s exact tests demonstrated these
overlapping changes were highly significant. In all 3 mutants, 31 transcript changes overlapped,
which represents 6%, 18%, and 44% of all altered transcripts in the Rbm8a, Eif4a3, andMagoh
mutants, respectively. As noted by Venn diagram, some transcript alterations were specific to
individual mutants (S2A Fig). This was especially evident in Rbm8a and Eif4a3mutants, and
suggests there could be roles for EJC components outside of the complex. Yet, taken together,
these data support the notion that EJC components also work together to selectively affect
mRNA levels at the onset of neurogenesis.
Given the significant overlap in transcript changes, we hypothesizedMagoh, Rbm8a, and
Eif4a3mutants influence common molecular and cellular pathways. To determine if this was
true, we performed gene set enrichment assays (GSEA) Kyoto Encyclopedia and Genes and
Genomes (KEGG) analysis on all 18,465 detectable genes from the transcriptome data, ranked
by p value. Of those pathways significantly altered in all 3 EJC mutants, we discovered enrich-
ment in only ribosome, proteasome, and p53 signaling (Fig 4G and S2 Table). This was also
evidenced by enrichment plots and STRING analyses (S3A–S3I Fig). Closer inspection of the
significantly altered transcripts within each KEGG category revealed extensive overlap amongst
the 3 mutants (S3B, S3D and S3F Fig). Gene ontology (GO) analyses using GSEA further cor-
roborated ribosomal alterations in all 3 haploinsufficient mutants (S2C Fig and S2 Table). The
directionality and degree of expression changes in ribosome-encoding transcripts were consis-
tent across all mutant mice (S2D Fig). Notably, inspection of only the significant transcript
changes for each mutant (q<0.05) showed that ribosomal-associated transcripts made up
Exon Junction Complex Control of Microcephaly
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Fig 4. Transcriptome analyses of E10.5Magoh, Rbm8a, and Eif4a3 haploinsufficient cortices reveal common downstream pathways. (A)
Diagrammatic overview of RNA sequencing analysis of E10.5 neocortices from indicated genotypes. (B) qPCR showing expression ofMagoh,
Rbm8a, and Eif4a3 in their respective mutant E10.5 cortices. (C) Heatmaps showing z-score transformed normalized expression for all affected
transcripts with an FDR corrected p-value, q< 0.05. Genes and samples were clustered using correlation distance with complete linkage. (D) Scatter
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11.4%, 6.5% and 7.5% ofMagoh, Rbm8a, and Eif4a3mutants, respectively. This indicates
altered protein homeostasis pathways, including the ribosome, are shared early consequences
of EJC haploinsufficiency.
To assess transcript regulation in an independent EJC model not reliant on Cre, we per-
formed RNA-sequencing on E10.5 neocortices from control (C57BL/6J) and germlineMagoh
haploinsufficient mice (MagohMos2/+) (n = 4 biological replicates each) (Fig 5A). Hierarchical
analysis revealed consistent expression changes inMagohMos2/+ compared to control litter-
mates (Fig 5B). Amongst the 23,577 genes detected, only 80 (0.3%) transcripts were differen-
tially expressed (q<0.05), and these were equivalently upregulated and downregulated (Fig 5C,
S1 Table). RT-qPCR validation confirmed alterations in two transcripts, Dclk1 and Tbr2,
with similar trends to RNA-seq (Fig 5D). Changes were more dramatic than in Emx1-Cre;
Magohlox/+, consistent with a more severe impact of theMagoh germline deletion [23,25].
GSEA KEGG analysis of all detectable transcripts revealed significant enrichment for ribosome,
proteasome, and p53 signaling components, amongst additional regulators of protein metabo-
lism (Fig 5E and S4A Fig). GO analysis also detected ribosomes as a top altered category (S4C
Fig). Of note, we observed overlap between Emx1-Cre;Magohlox/+ andMagohMos2/+ transcripts
within the ribosome, proteasome, and p53 categories (S4B Fig). Altogether, these transcrip-
tome analyses from 4 independent mouse lines, including 2 models ofMagoh, demonstrate
that EJC haploinsufficiency influences a few common pathways including ribosome, proteo-
some and p53 signaling.
Haploinsufficiency forMagoh, Eif4a3, and Rbm8a causes aberrant
splicing of RNA regulatory proteins
Given the requirement of the EJC in splicing and NMD, we next assessed splicing isoforms in
the transcriptome data. Consistent with a published study in human cell lines [36], wide-
spread splicing changes were evident in all 3 EJC mutants compared to control (S3 Table). We
measured specific splicing events relative to all annotated alternative splicing (AS) events
using Mixture-of-Isoforms (MISO) software [37,38]. Comparing the changed AS events to all
annotated AS events, the distribution of AS types was significantly altered, with a 2–3 fold
enrichment in retained intron (RI) events in all 3 EJC mutants (p<0.001) (Fig 6A). Amongst
the RI events, 61%, 70%, and 23% were increased inMagoh, Rbm8a, and Eif4a3 haploinsuffi-
cient mutants, respectively (Fig 6B, S3 Table). In Emx1-Cre;Rbm8alox/+, 91% of RI events
introduced a premature stop codon, which presumably leads to mRNA degradation through
NMD (S3 Table). We validated several events, includingMapk13 in E11.5 Emx1-Cre;
Rbm8alox/+ brains and Fus inMagohMos2/+ brains, noting alterations consistent with predic-
tions (Fig 6E and S5A Fig). Thus, the enrichment of RI events could be due to inefficient
NMD activity [12,14]. Consistent with previous findings that EJC Drosophilamutants cause
increased RI events [39–41], our data suggest EJC components influence mRNA splicing in
NSCs.
We next used bioinformatics analysis to determine if there are overlapping classes of splic-
ing variants in the 3 EJC mutants. We performed KEGG analysis on those genes with signifi-
cant alterations in splice variant expression (Bayes factor> 20) using the Database for
plots of transcripts significantly upregulated (green dots) and downregulated (red dots) in E10.5 Emx1-Cre;Magohlox/+, Emx1-Cre;Rbm8alox/+, and
Emx1-Cre;Eif4a3lox/+ cortices (q<0.05). (E, F) qRT-PCR validation at E11.5 compared to relative RNA-seq values of Tbr2 (E) andNgn2 (F) in the
indicated genotypes. For RNA-seq and qPCR, each control was normalized to 1.0 and compared to mutants. (G) Graph depicting common KEGG
terms identified by GSEA analysis that were significant in all 3 EJC mutants, showing corresponding enrichment score. Student’s t test (B,E,F), Error
bars, S.D. *, p<0.05, **, p<0.01, ***, p<0.001.
doi:10.1371/journal.pgen.1006282.g004
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Annotation, Visualization and Integrated Discovery (DAVID). These analyses showed com-
mon terms amongst all EJC mutants, including a significant enrichment of spliceosome (Fig
6F). GO analysis reinforced this finding, with enrichment of RNA regulatory categories includ-
ing ribonucleoproteins and ribosomes (S4 Table). 51 identical alternative splicing events were
predicted among all 3 EJC mutants. String analyses of these genes revealed two clusters for
Fig 5. Transcriptome analyses of E10.5Magoh germline haploinsufficient brains identifies alterations in ribosome and p53 signaling
pathways. (A) Diagrammatic overview of RNA sequencing analysis of E10.5 neocortices (dotted lines) from indicated genotypes. (B) Heatmaps
showing z-score transformed normalized expression for control andMagohMos2/+. Genes and samples were clustered using correlation distance
with complete linkage. (C) Scatter plot of transcripts significantly upregulated (green dots) and downregulated (red dots) in E10.5MagohMos2/+
cortices (q<0.05), n = 4 biological replicates each. (D) Validation and RNA-seq values for Dclk1 and Tbr2 in indicated E11.5 mutant dorsal
neocortices. Controls were normalized to 1.0. (E) Graph depicting top ranked KEGG terms by GSEA analysis inMagohMos2/+ showing
corresponding fold enrichment. Student’s t test (D), Error bars, S.D. *, p<0.05, ***, p<0.001.
doi:10.1371/journal.pgen.1006282.g005
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ribosome regulation and splicing regulation (S5B Fig). These data suggest that in addition to
influencing transcript expression, EJC components have been co-opted to impact splicing of
RNA regulators. Together, this implies an EJC dependent regulatory network that fine-tunes
gene expression at the RNA level.
Fig 6. Haploinsufficiency for EJC components alters mRNA splicing of splicing regulators. (A) Bar graph showing alternative splicing events for
each mutant relative to the control. (B-D) Clustered column graphs of the distribution of ψ values of all identified intron retention (RI) events in E10.5
dorsal cortices for each EJCmutant, using a threshold of 20 for Bayes factor.Ψ<0 indicates higher probability for the mutant to have intron retention
when compared to the control. (E) Top: IGV view of increasedMapk13 intron 6–7 reads in red frame. Primers indicated as arrows. Bottom: RT-PCR
showing increasedMapk13 RI isoforms in Emx1-Cre;Rbm8alox/+ E11.5 dorsal cortices compared to the control. (F) Bar graph of common KEGG terms
that were significant in all 3 EJCmutants, showing corresponding enrichment score. ANOVA (A), Modified fisher’s exact test (F), *, p<0.05, **,
p<0.01, ***, p<0.001.
doi:10.1371/journal.pgen.1006282.g006
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Proteomic analyses reveal core EJC components influence protein
levels of ribosomal components and RNA processing factors at the
onset of neurogenesis
We next measured the proteomes of control,Magoh, Rbm8a, and Eif4a3 haploinsufficient
E11.5 neocortices using quantitative proteomic liquid chromatography/mass spectrometry
(LC_MS/MS) analyses (n = 3 biological replicates each) (Fig 7A, S5 Table). We detected 3,587
proteins in the control and assessed relative levels of these proteins in each of the mutants.
Magoh, Eif4a3, and Rbm8a haploinsufficiency led to significant alterations in 3.8%, 1.5%, and
4.3% of the detectable proteome, respectively (p<0.05). Consistent with our transcriptome
analysis, the proteomes of the various mutants showed both overlapping and independent
alterations (S6A Fig).
We next asked if there were common alterations amongst those proteins significantly
altered in the 3 EJC mutants. Using KEGG DAVID analysis to examine only significant protein
changes (p<0.05), we identified ribosomes as the only pathway enriched in all 3 EJC mutants,
significant in 2 of the mutants (Fig 7B). GO analysis showed components of ribosomes and
ribonucleoprotein complexes amongst the most significantly enriched categories (Fig 7C, S6
Table). We performed STRING analysis of all altered proteins in the EJC mutants within the
largest GO term, “Ribonucleoprotein Complex,” which included ribosome components and
splicing factors (Fig 7D). This analysis reinforced strong regulatory networks present amongst
proteins downstream of the EJC, and the consistent directional changes evident in all 3
mutants. Closer inspection of all significant protein changes within each mutant showed that
ribosomal proteins made up 7.9%, 5.8%, and 7.5% ofMagoh, Rbm8a, and Eif4a3mutant
changes, respectively. A large fraction of ribosomal proteins changed consistently across all 3
mutants, showing up and down regulation at the protein level (S6B Fig). Altogether these geno-
mic and proteomic analyses support the notion that ribosome and ribonucleoprotein alter-
ations are major early defects associated with EJC deficiency in the developing brain.
Activation of p53 is a major contributor to microcephaly of EJC mutant
mice
The omics analyses pointed to several common pathways that are dysregulated at the onset of
neurogenesis, and suggested candidate molecules that could be relevant for EJC mutant pheno-
types. We hypothesized that p53 signaling, in particular, was a major contributor to EJC-medi-
ated microcephaly. Activated p53 is a key regulator of apoptosis and defective cell cycle
progression [42], two major phenotypes of EJC mutant brains. Moreover, p53 target transcripts
were upregulated in all 3 conditional EJC mutants andMagoh germline mutant (Figs 4 and 5,
S1 Table). Additionally, a correlation has been previously observed in p53 transcript changes
inMagoh germline brains and induced radiation [43]. Altogether these data suggest p53 activa-
tion may be a common critical node in disease pathogenesis following EJC impairment. We
thus probed the relationship between EJC haploinsufficiency and p53 signaling, by assessing
p53 nuclear accumulation in embryonic brain sections, as a proxy for pathway activation [26].
Haploinsufficiency forMagoh, Rbm8a, and Eif4a3 led to a significant accumulation of p53 in
the VZ compared to control brains, which showed no evidence of p53 accumulation (Fig 8A–
8J). Western blotting confirmed accumulation of p53 protein in Eif4a3mutant cortices (S7A
Fig). P53 activation was evident in E11.5 Rbm8amutants (Fig 8E and 8F), prior to the onset of
apoptosis [24], and was specifically enriched in PAX6-positive NSCs (Fig 8I and 8J). This dem-
onstrates that p53 is activated in EJC haploinsufficient NSCs.
We hypothesized that p53 activation contributes to microcephaly phenotypes of all 3 EJC
mutants. To directly assess this, we crossed Emx1-Cre;Magohlox/+, Emx1-Cre;Rbm8alox/+, and
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Fig 7. Proteomic analysis of E11.5 EJCmutant brains reveals alterations in levels of ribosome-associated proteins and
ribonucleoproteins. (A) Diagrammatic representation of workflow to perform proteomic analysis of E11.5 dorsal cortices. (B, C) Bar graph
of all common enriched KEGG terms (B) and top common GO terms (C) among all 3 EJC mutants showing corresponding fold enrichment
and P values. (D) STRING network analysis of proteins within the broadest GO category, “Ribonucleoprotein Complex” altered in any of the
3 EJCmutants. Stronger associations are represented by thicker lines, and circles are colored based upon alteration in 1 or more mutants
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Emx1-Cre;Eif4a3lox/+, onto a p53lox/lox null background. We collected E18.5 embryos and mea-
sured cortical area. Compared to control, Emx1-Cre;p53lox/lox did not alter brain size (Fig 9A,
9C, 9F, 9H, 9K and 9M). As expected, cortical area was significantly reduced in mice haploin-
sufficient forMagoh, Rbm8a, or Eif4a3, to a similar degree seen in adults (Compare Fig 9B, 9G
and 9L to Fig 3). Strikingly, for all 3 EJC mutants the microcephaly was significantly, albeit par-
tially, rescued in a p53mutant background (Fig 9D, 9I and 9N). Amongst the 3 EJC mutants,
the extent of p53-mediated rescue varied and was most effective in the least severe microceph-
aly mutant,Magoh (Fig 9E, 9J and 9O). These data indicate that p53 activation is a major cause
of microcephaly in all 3 EJC mutants. Our data also suggest that for Rbm8a and Eif4a3, addi-
tional p53 independent factors likely contribute to the reduced brain size.
To elucidate the nature of the p53-mediated rescue we examined apoptosis and neuron
number. Amongst the 3 core EJC components, reduced RBM8A levels are the most strongly
associated with human microcephaly [19,21,44]. Given this clinical relevance, we focused our
analysis on the Rbm8amutant. As p53 is essential for induction of apoptosis, we first assayed
whether p53 ablation rescued apoptosis in the Rbm8amutant. As predicted, CC3 immunos-
taining revealed complete rescue of apoptosis in E12.5 Emx1-Cre;Rbm8alox/+;p53lox/lox brains
(S7B–S7D Fig). Thus p53 activation promotes apoptosis downstream of Rbm8a.
We next examined neuronal layers of E18.5 brains (Fig 10A–10D). As we have previously
shown [24], Rbm8amutant brains are missing most of their pallium (Fig 10B). In the Emx1-
Cre;Rbm8alox/+;p53lox/lox brains, the pallium is restored, consistent with the rescue of apoptosis
(Fig 10D). We asked if p53 loss impacts neuronal layers, focusing on the tissue adjacent to the
pallial-subpallial boundary which is still present in Rbm8amutants [24]. We quantified both
deep and superficial neuronal markers which are generated at early and late stages of neuro-
genesis, respectively [4]. As predicted, Cux1+ neurons (layer II/III) were nearly ablated in
Emx1-Cre;Rbm8alox/+ brains, compared to control or p53 alone (Fig 10E–10G). In contrast, in
p53;Rbm8a compound mutant brains Cux1+ neuron number was largely rescued (Fig 10H and
10M). Another marker of both superficial and some deep layer neurons, Satb2, was reduced in
and level of significance. Two networks of splicing regulators and ribosome-associated proteins are detected. Modified fisher’s exact test, *,
p<0.05, **, p<0.01, ***, P<0.001.
doi:10.1371/journal.pgen.1006282.g007
Fig 8. EJC haploinsufficiency induces P53 activation. (A-J) Coronal sections of cortices from E13.5 Emx1-Cre (A), E13.5 Emx1-Cre;Magohlox/+ (B),
E12.5 Emx1-Cre (C, G, I), E12.5 Emx1-Cre;Eif4a3lox/+ (D), E11.5 Emx1-Cre (E), E11.5 Emx1-Cre;Rbm8alox/+ (F), and E12.5 Emx1-Cre;Rbm8alox/+ (H,J)
embryonic cortices stained for Hoechst (blue), P53 (green), and Pax6 (red), with co-localization indicated in yellow. Sections were demarcated with
dotted lines. Each image is representative of at least 3 independent biological samples. Scale bar, A-J, 50 μM.
doi:10.1371/journal.pgen.1006282.g008
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Fig 9. Loss of p53 partially rescuesmicrocephaly ofMagoh, Rbm8a, and Eif4a3 haploinsufficient mutants. (A-D, F-I, and K-N) Whole mount
brains of E18.5 embryos with indicated genotypes. (E, J, O) Quantification of cortical area in E18.5 embryonic brains with indicated genotypes. Dotted
lines demarcate the dorsal cortical areas measured. The surface area of littermate control brains was set to 100. ANOVA with Tukey posthoc, **,
p<0.01, ***, p<0.001, NS, not significant. Error bars, S.D. n = 3–9 biological replicates each. Scale bars, A-D, E-I, and K-N, 1 mm.
doi:10.1371/journal.pgen.1006282.g009
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Fig 10. Loss of p53 partially rescues neuron number and distribution associated with Rbm8a haploinsufficiency. (A-D) Coronal
sections of E18.5 brains of indicated genotypes stained with Hoechst (white). (E-L) Regions of coronal sections indicated in (A-D, red
dotted square) stained for Cux1 (E-H) and Tbr1 (I-L). (M, N) Quantification of Cux1+ (M) and Tbr1+ (N) density within a 250 μm radial
column for indicated genotypes. (O, P) Bar graphs depicting density of Tbr1+ neurons in VZ/SVZ (bin 1–2, O) and cortical plate (bin 3–5,
P) of indicated genotypes. Bins were quantified as indicated in I. Brackets denote general boundaries of Cux1 and Tbr1 layers. ANOVA
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Emx1-Cre;Rbm8alox/+, but partially rescued in a p53 null background (S7E–S7I Fig)[45,46].
We also examined earlier born deep layer Tbr1+ neurons (Fig 10I–10L). As we previously
described [24], in Emx1-Cre;Rbm8alox/+ brains Tbr1 number is normal but distribution is
skewed basally (Fig 10I, 10J, 10K and 10N–10P). This is consistent with our previous finding
that at early stages of development, Tbr1 density is increased in Rbm8amutants, perhaps due
to increased neuron production [24]. In Emx1-Cre;Rbm8alox/+;p53lox/lox brains, aberrant Tbr1-
+ neuron distribution was restored to normal (Fig 10L, 10O and 10P). These analyses show
that in Rbm8amutants, p53 activation influences the number and distribution of neurons gen-
erated at different stages of neurogenesis, and plays a particularly important role in genesis of
upper layer neurons. Taken together, our data implicate p53 activation as a key node in the
microcephaly pathology following EJC impairment.
Discussion
The EJC is a central regulator of mRNA metabolism, yet how its molecular roles translate into
physiological functions relevant for disease has been poorly understood. Here we used mouse
haploinsufficiency models for the 3 core EJC components to demonstrate their common
requirements for neurogenesis and proper brain size. We employed transcriptomics and prote-
omics to identify converging molecular pathways regulated by the EJC at the onset of neuro-
genesis. Our unbiased analyses demonstrate that reduced levels ofMagoh, Eif4a3, or Rbm8a
lead to altered expression of ribosomal components, splicing changes, and aberrant p53 signal-
ing. We focused on the p53 pathway, demonstrating that aberrant p53 activation is a major
contributor to EJC-mediated microcephaly. Given that human mutations in EJC components
are associated with neurodevelopmental diseases, our study suggests these pathologies may be
due in part to aberrant p53 activation.
EJC controls gene expression in neural stem cells
Our study elucidates several layers of EJC-dependent gene expression in the developing neo-
cortex. Whereas EJC-dependent targets are known in Drosophila and immortalized cells
[35,36], our study is the first to discover EJC-dependent gene expression in a mammalian stem
cell population. We demonstrate that EJC haploinsufficiency alters only a small fraction of the
transcriptome, and these changes are disproportionately enriched for ribosomal proteins, pro-
teasome components, and p53 signaling. Thus, the EJC may be especially important in regula-
tion of protein homeostasis machinery. We also find the 3 core EJC proteins converge in
regulating alternative splicing events. In particular we identify aberrant intron retention events
which are suggestive of roles in mRNA splicing and NMD, and are consistent with genomic
studies of EJC depletion in Drosophila and mammalian cells [36,39–41]. Notably these splicing
changes are enriched for both spliceosomal and ribosomal components. Alterations in ribo-
somes are also observed at the protein level. Altogether, these analyses indicate the EJC is inte-
gral to an RNA regulation network controlling neurogenesis.
These findings raise several fascinating questions. Although we focused on common EJC
regulatory pathways, our data also highlight there are unique targets of individual EJC compo-
nents. In future studies it will be of interest to consider potential independent roles for EJC
components outside of the complex in neurogenesis. Another interesting question is how the
EJC differentially regulates its targets in individual cells. For example, although we measured
with Tukey posthoc *, p<0.05, **, p<0.01, ***, p<0.001, ns, not significant. Error bars, S.D. n = 2–3 biological replicates each. Scale
bars, A-L, 50 μm.
doi:10.1371/journal.pgen.1006282.g010
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genomic changes in tissue that is mainly composed of 1 cell type, neuroepithelial progenitors,
observed transcript and splicing differences could be attributed to progenitors in different cell
cycle states. Moreover, it will be of interest to determine if the same pathways are regulated by
the EJC in non-Emx1-derived cell types.
P53 attenuation rescues microcephaly caused by EJC
haploinsufficiency
We demonstrate that EJC mutant mice all exhibit profound microcephaly, which is signifi-
cantly rescued by p53 deletion. Detailed analysis of Rbm8amutants reveal that p53 attenuation
partially restores superficial neuron number and distribution of deep layer neurons. Thus, the
dramatic loss of upper layers in Rbm8amutants is due, in part, to p53 activation. At least 2 sce-
narios could explain this rescue. P53 induction of apoptosis may severely reduce both neuron
and progenitor number, particularly at later stages when upper layers are produced. Aberrant
p53 activation may also influence stem cell divisions and thus their progeny. Our lab previously
showed increased mitotic index inMagoh and Rbm8amutant NSCs [23,24,26]. Mitotically
delayedMagohmutant NSCs preferentially produce neurons and apoptotic progeny, at the
expense of NSCs [26]. We find that p53 activation is evident at E10.5, which precedes the onset
of mitotic defects at E11.5 and E12.5. Given this sequence of events, it is tempting to speculate
that aberrant p53 activation may influence progenitor (and ultimately neuron) number by
delaying mitosis. Future experiments will be useful for evaluating if this relationship is correla-
tive or causal.
How might p53 be activated by EJC dysfunction? It is plausible that ribosomal alterations
contribute to p53 activation, as evidenced in many examples from the literature for genes con-
trolling ribosome biogenesis [42,47–51]. Alternatively, p53 could be activated independent of
the ribosome, as seen in the pancreas [52]. The EJC could also directly regulate RNA metabo-
lism of p53 pathway components, as has been observed in splicing of apoptotic regulators [53].
The mechanisms contributing to p53 activation in EJC models are a topic of future interest.
Beyond p53: other alterations associated with EJC haploinsufficiency
For Eif4a3 and Rbm8amutants, p53 rescue was incomplete, suggesting there must be addi-
tional EJC-dependent pathways mediating early stages of neurogenesis. Our analyses implicate
several promising candidates. Reduced expression of canonical neurogenesis regulators,
including Ngn2, Tbr2, and NeuroD6, could contribute to cell fate changes in the neocortex. All
4 EJC mutants also showed alterations in components of the proteasome, indicating that the
EJC could influence neurogenesis by regulating protein homeostasis. Our data also identify
ribosomal alterations at the transcriptome, splicing, and proteomic level, suggesting ribosome
regulation could contribute to EJC-dependent microcephaly. Indeed, human genetic studies
suggest that ribosome biogenesis defects cause neurodevelopmental diseases [54]. Of the signif-
icant (FDR<0.05) changes in 3 different mutants, ribosomal transcripts made up 5–11%, well
above the fraction expressed in progenitors, a finding which is reinforced with unbiased GSEA
analysis.
How might the EJC influence expression of ribosomal components? The EJC could directly
regulate ribosome biogenesis. Indeed, ribosome biogenesis defects are seen in Fal1p S. cerevi-
siaemutants [55,56] and Eif4a3 siRNA-depleted mammalian cells [56–58]. Alternatively,
highly expressed genes, which include both ribosomal and proteasome components, could be
especially sensitive to EJC levels. Another possible explanation for our results is that ribosome
alterations are an indirect result of overall cellular stress. This idea is supported by the observa-
tion that some ribosome-encoding transcripts are not altered in all 3 mutants. It is also notable
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that ribosomal transcripts at E10.5 were nearly universally upregulated, whereas one day later
the proteins were differentially altered. This could be due to differences in RNA versus protein
regulation or could suggest compensatory responses to restore ribosomal levels in the brain.
Understanding the nature of how the EJC influences ribosome stoichiometry, and how this
may influence microcephaly, will be an important question for the future.
Roles for the EJC in neurogenesis and neurodevelopmental disorders
Mutations and copy number variations in core and peripheral EJC components are strongly
associated with neurodevelopmental deficits in humans, yet the etiology of these pathologies is
poorly understood. Microdeletions and duplications of a 15-gene locus containing RBM8A are
associated with microcephaly, macrocephaly, autism, and epilepsy [19,20]. Compound inheri-
tance of this deletion and a regulatory RBM8Amutation is responsible for TAR syndrome,
a congenital malformation of blood and skeletal systems which can also present with neurolog-
ical deficits [21]. Moreover, regulatory EIF4A3mutations cause a craniofacial disorder
presenting with learning and language disabilities [22]. Intriguingly, both craniofacial and neu-
rodevelopmental anomalies are associated with disruption of p53 signaling and ribosomal
impairments [49,50,59,60]. It is notable the EJC downstream splicing changes include several
genes, such as RPL10, which are mutated in patients with neurodevelopmental disorders [60].
Thus, it is interesting to consider whether some of the expression changes we have identified in
mouse models may contribute to EJC disease etiology.
Altogether, based on our discoveries, we propose aberrant p53 signaling contributes to the
pathology of EJC related disorders and that modifications of p53 signaling may be of potential
therapeutic interest. It is tempting to speculate that EJC diseases could be considered as riboso-
mopathies. Going forward, the EJC haploinsufficient mouse mutants we have generated pro-
vide valuable models for understanding the etiology of microcephaly and dissecting cell
autonomous requirements in NSCs. Future studies using ubiquitous knockout of EJC compo-
nents may help to further model other disease manifestations. In summary, our findings dem-
onstrate new mechanisms to explain how EJC haploinsufficiency causes microcephaly, which
has implications for understanding physiological functions of the EJC in the developing brain
and in disease pathogenesis.
Materials and Methods
Ethics statement
All experiments were performed in agreement with the guidelines from the Division of Labora-
tory Animal Resources from Duke University School of Medicine and IACUC.
Mouse husbandry and generation of conditional Eif4a3 allele
Plug dates were defined as embryonic day (E) 0.5 on the morning the plug was identified. The
conditional targeting vector for ES cell targeting was designed and generated by the Transgenic
Facility at Duke University Cancer center. Positive ES clones were selected by performing long-
range PCR of both arms. For long-range PCR of 5’ arms, the following conditions were used:
94°C X 1 min (1X); 98°C X 10 s, 60°C X 15 s, 68°C X 8.5 min (40X); 72°C X 10 min. 5’ F1:
GTCCCAGAAATATCAGTGAGAATC; 5’ R1:CTTGTCATCGTCGTCCTTGTAGTC. For
long-range PCR of 3’ arms, the following conditions were used: 94°C X 2 min (1X); 98°C X 10
s, 60°C X 15 s, 68°C X 2.5 min (40X); 72°C X 10 min. Positive clones were electroporated into
CD1 blastocysts, and the resulting chimeras were mated to C57BL/6J females to obtain germ-
line transmission. For genotyping Eif4a3lox mice, the following conditions were used: 94°C X 3
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min (1X); 94°C X 15 s, 62°C X 20 s, 72°C X 30s (30X); 72°C X 10 min (1X). 5’ forward:
CTTGCAGTTGTCTTTCTGCGG; 3’ Reverse: CACACATGGCGATCCGCTCG. The follow-
ing strain was acquired from Jackson labs: Emx1-Cre (B6.129S2-Emx1tm1(cre)Krj/J).
Western blot and RT-qPCR analyses
E10.5 neocortices and E11.5 dorsal cortices were collected from Emx1-Cre, Emx1-Cre;
Eif4a3lox/+, Emx1-Cre;Rbm8alox/+, and Emx1-Cre;Magohlox/+ mice and lysed in RIPA lysis
buffer with protease inhibitors (Pierce, Rockford, IL). Cortical lysates were run on 4–20%
pre-casted SDS–Polyacrylamide gels (Bio-Rad). For Pax6 and P53 blots, stain free gels were
used for total protein normalization. Gels were transferred onto nitrocellulose membranes
and blotted using the following primary antibodies: rabbit anti-Eif4a3 (1:200, Santa Cruz),
rabbit anti-Pax6 (1:1,000, Millipore), rabbit anti-p53 (1:1,000, Leica) and mouse anti-α-Tubu-
lin (1:10,000, Sigma). Blots were developed using ECL reagent (Pierce). Densitometry was
performed using ImageJ. Final values were quantified by normalizing EJC protein levels to
loading controls (1:10,000, Tubulin, Sigma) or UV-induced Stain-free pre-casted gel (Bio-
Rad), and analyzed for significance using a Student’s t test. For qPCRs, whole neocortices
from E10.5 and dorsal neocortices of E11.5, and E12.5 and E14.5 embryos were collected
from C57BL/6J (wild-type), Emx1-Cre, Emx1-Cre;Eif4a3lox/+, Emx1-Cre;Rbm8alox/+, and
Emx1-Cre;Magohlox/+ embryos and RNA was extracted using Trizol reagent (Invitrogen)
followed by the RNeasy kit (Qiagen). cDNA was prepared according to the iScript kit (Bio-
Rad). qPCR was performed in triplicates using Taqman probes (Life Technologies):
Rbm8a (Mm04214345_s1), Eif4a3 (Mm00836350_g1),Magoh (Mm00487546_m1), Ngn2
(Mm00437603_g1), Tbr2 (Mm01351984_m1), Dclk1 (Mm00444950_m1) and Gapdh
(4352339E). Sybr Green iTaq (Biorad) was performed with primers designed for Gste1 (5’For-
ward-CCAGAGCAAAGAGGACCAAG and 3’ Reverse-CCGTGAGAACTTTGGGGTTA),
NeuroD6 5’ Forward-GCCTCAATGATGCTCTGGACAA and 3’ Reverse- CTCTTGCCA
ATCCTCAGAATTTCAG), and β-Actin (5’ Forward- CCTTCTTGGGTATGGAATCCTG
and 3’ Reverse- GTTGGCATAGAGGTCTTTACGG). For wild-type samples at different
developmental stages, semi-quantitative qRT-PCR was performed. A standard curve was gen-
erated with a 5 serial 10-fold dilution of cDNA from an independent E14.5 wildtype embryo.
Final values were normalized to Gapdh loading control. For E10.5 control and conditional
mutant samples, comparative qRT-PCR was performed. Values were normalized to Gapdh
control. For each genotype, 3 embryos were examined, a student’s t test was run to determine
the significance. For all experiments, 3 biological samples for each genotype were used.
Immunohistochemistry and quantification of tissue sections
Brains were fixed overnight in 4% paraformaldehyde (PFA) at 4°C, followed by submersion in
30% sucrose until sinking, as previously described [23]. Brain cryostat sections (20 μm) were
prepared and stored at -80°C until use. Sections were permeabilized with 0.25% TritonX-100
for 10 min and blocked with MOM block reagent (Vector laboratories) for 1 hour at room tem-
perature (RT). Sections were incubated with primary antibodies for 2 hours at RT or overnight
at 4°C. Sections were then incubated in species appropriate secondary antibodies and Hoechst
for 15 min at room temperature. The following primary antibodies were used: rabbit anti-
Magoh (1:200, Proteintech), rabbit anti-Rbm8a (1:200, Bethyl), rabbit anti-Eif4a3 (1:200,
Bethyl), rabbit anti-CC3 (1:200; Cell Signaling), rabbit anti-Pax6 (1:1,000; Millipore); rabbit
anti-PH3 (1:200, Millipore), rabbit anti-Satb2 (1:1000; Abcam), anti-Cux1 (1:250, Santa Cruz);
mouse anti-Pax6 (1:50; DSHB); rabbit anti-p53 (1:250, Leica), mouse anti-TuJ1 (1:400; Cov-
ance). The following secondary antibodies were used: Alex Fluor 488, Alex Fluor 568, Alex
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Fluor 594 (1:200–400; Invitrogen) and Hoechst (1:1000; Invitrogen). High magnification
images were captured using a Zeiss Axio Observer Z.1 microscope coupled with an apotome.
Cortical thickness was measured with Zen software. Quantifications were performed using
ImageJ. A minimum of 3 sections from anatomically comparable regions per embryo and 3
biological replicates from control and mutants were measured/quantified.
RNA-Seq, splicing and bioinformatics
Control and EJC mutant embryonic neocortices were dissected at E10.5. Samples were flash-
frozen in liquid nitrogen and stored at -80°C until further treatment. RNA was extracted with
Trizol (Invitrogen) followed by micro-RNeasy kit (Qiagen) according to manufacturer’s proto-
col. The library was generated with Kapa stranded mRNA-seq Kit. The fragmented poly-A
RNAs were sequenced using Illumina Hi-Seq 2000 double end sequencing with 100nt length.
RNA-seq data was processed using the TrimGalore toolkit (http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore) which employs Cutadapt to trim low quality bases and
Illumina sequencing adapters from the 3’ end of the reads [61]. Only pairs where both reads
were 20 nt or longer were kept for further analysis. Reads were mapped to the NCBIM38r73
version of the mouse genome and transcriptome using the STAR RNA-seq alignment tool
[62]. Reads were kept for subsequent analysis if they mapped to a single genomic location.
Gene counts were compiled using the HTSeq tool (http://www-huber.embl.de/users/anders/
HTSeq/). Only genes that had at least 10 reads in any given library were used in subsequent
analysis. Normalization and differential expression was carried out using the EdgeR Biocon-
ductor package with the R statistical programming environment [63]. The exact test method
was used to identify differentially expressed genes between the different mouse genotypes.
Inspection of reads using integrative genomics viewer (IGV) software confirmed altered regula-
tion of pseudogenes. Heatmaps were prepared for z-score transformed normalized expression
for genes with an FDR, q<5%. To calculate significant overlap for Venn diagrams the following
criteria were used: genes must with a q<0.05 and using a Fisher’s Exact Test for overlap
between any two conditions. For alternative splicing analysis, Mixture-of-isoforms (MISO)[38]
model was used to analyze RNA-Seq data and estimate the percent of splicing isoforms (C val-
ues, for ‘Percent Spliced Isoform’), and the differentially spliced events are identified using a
stringent filter (bayes-factor>20). The program was run with pooled samples of 3 biological
replicates to reduce sampling biases. Validation of RI events was performed by RT-PCR with
cDNA prepared from E11.5 dorsal cortices of control and EJC mutant embryos. The following
primers were used: Fus Ex6 Forward: GGCCAAGATCAGTCCTCTATGAGT, Fus Ex8
Reverse: CATGACGAGATCCTTGATCCCGA,Mapk13 Ex6 Forward: GCAACCTGGCTGT
GAATGAA, andMapk13 Ex7 reverse: CTGGTTGTAATGCATCCAGCTG.
Pathway analyses for RNA seq and proteomics
For bioinformatic analysis of RNAseq Gene Set Enrichment Analysis (GSEA) was performed
by creating a pre-ranked list of all detected transcripts, ranked by 1 minus the p value. The
ranked list was imported into the GSEA software (GSEA v2.2.2, Broad Institute) and analyzed
using the pre-ranked gene list function. The data bases used were KEGGv5.1 and GOv5.1.
Common GSEA terms were cross compared among the 3 mutant strains and plotted according
to their normalized enrichment score. The statistical test utilized by GSEA is the Kolmogorov-
Smirnov statistical test. Venn diagrams include all genes that were identified as enrichment by
the GSEA analysis within a given KEGG term. For splicing and proteomics analysis, we deter-
mined enriched pathways by assessing only significant hits (splicing analysis: MISO, Bayes
factor>20 and proteomics, p<0.05). DAVID Annotation, Visualization and Integrated
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Discovery v6.7 was used to analyze significant changes by KEGG and gene ontology (GO) anal-
ysis (including biological process, molecular function, and cellular component). Significance of
enrichment in GO term analyses was calculated using the p value function given from a modi-
fied Fisher’s exact test by the DAVID database. For splicing analysis, STRING (Search Tool for
the Retrieval of Interacting Genes/Proteins) analysis was carried out with transcripts show sig-
nificant splicing changes (Bayes>20) in all 3 EJC mutants. For proteomic analysis, STRING
was carried out with significantly changed (p<0.05) proteins in the “ribonucleoprotein com-
plex” GO term. All components not connected to other genes/proteins were not included in
figures.
Proteomics and bioinformatics
We performed relative quantitation proteomic study using the Duke Proteomics Core Facility.
E11.5 dorsal cortices were dissected in cold PBS and flash-frozen in liquid nitrogen. Samples
were stored in -80°C until use. 200 μl of 8M urea in 50 mM ammonium bicarbonate was added
to E11.5 dorsal cortices. Samples were subjected to 3 rounds of probe sonication for 5s each
with an energy setting of 30%. Samples were then centrifuged at 12,000g and 4°C for 5 minutes.
All samples were run by LC/MS/MS and total ion current was used to normalize sample load-
ing for final analysis. Samples were supplemented with 800 μl of 50 mM ammonium bicarbon-
ate to reduce the urea concentration to 1.6M. Samples were reduced with 10 mMDTT at 80°C
for 15 min and then alkylated at 25 mM iodoacetamide at room temperature for 30 min. Tryp-
sin (1.7 μg) was added to each sample and allowed to proceed for 18 hr at 37°C. Samples were
then acidified with 6 μl of TFA and subjected to a C18 cleanup using the 50 mg (1 cc) C18 Sep-
Pak columns (Waters). After elution, the samples were spun to ~50% dryness in the vacuum
centrifuge, frozen, and lyophilized to dryness. Samples were randomized in their run order and
QC samples were run periodically throughout the acquisition window. Samples were initially
resuspended in 12 μl of 1% TFA/2% acetonitrile with 10 fmol/μl yeast alcohol dehydrogenase.
To create a “QC pool” sample to assess analytical reproducibility, 3 μl of each sample was
removed and pooled. Quantitative LC/MS/MS was performed on 2 μl of each sample, using a
nanoAcquity UPLC system (Waters Corp) coupled to a Thermo QExactive Plus high resolu-
tion accurate mass tandem mass spectrometer (Thermo) via a nanoelectrospray ionization
source. Briefly, the sample was first trapped on a Symmetry C18 300 mm × 180 mm trapping
column (5 μl/min at 99.9/0.1v/v water/acetonitrile), after which the analytical separation was
performed using a 1.7 μmAcquity BEH130 C18 75 mm × 250 mm column (Waters Corp.)
using 90-min linear gradient of 5 to 40% acetonitrile with 0.1% formic acid at a flow rate of 400
nl/min with a column temperature of 55°C. Data collection on the QExactive Plus mass spec-
trometer was performed in a data-dependent acquisition (DDA) mode of acquisition with a
r = 70,000 (@ m/z 200) full MS scan from m/z 375–1600 with a target AGC value of 1e6 ions
followed by 10 MS/MS scans at r-17,500(@ m/z 200) at a target AGC value of 5e4 ions. Follow-
ing the 12 LC-MS/MS analyses, data were imported into Rosetta Elucidator v3.3 (Rosetta Bio-
software, Inc), and all LC-MS/MS runs were aligned based on the accurate mass and retention
time of detected ions (“features”) which contained MS/MS spectra using PeakTeller algorithm
(Elucidator). A mean normalization of the high confidence identified peptide features exclud-
ing the highest and lowest 10% of the identified signals (i.e. a robust mean normalization) was
then employed. The relative peptide abundance was calculated based on area-under-the-curve
(AUC) of aligned features across all runs. Database searching was performed within Mascot
Server v2.5 (Matrix Science) and annotated using the Peptide Teller algorithm within Rosetta
Elucidator at a peptide false discovery rate of 1%. Proteins representing membrane, nuclear
and cytoplasmic fractions were present in the data.
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Supporting Information
S1 Fig. Analysis of conditional Eif4a3 haploinsufficient mutant. (A) In situ hybridization of
Eif4a3 in sagittal E14.5 mouse section, showing enrichment in the ventricular and sub-ventric-
ular zones (arrowheads) relative to the cortical plate (CP). Images are from www.genepaint.org
(Visel et al. 2004). (B) Representative PCR genotyping result from Emx1-Cre (control) and
Emx1-Cre;Eif4a3lox/+ mice. Note a single band (432 bp) in control and two bands (432 bp and
490 bp) in Emx1-Cre;Eif4a3lox/+. (C) Representative western blot of Pax6. (D) Quantification
of Pax6 expression from E10.5 cortical lysates. Error bars, S.D, n = 3 biological replicates each.
(TIF)
S2 Fig. RNA seq Validation and analysis of EJC mutants. (A) Venn Diagrams showing the
overlap of significant transcript changes (q<0.05) among the 3 EJC mutants. For pairwise com-
parisons between datasets, the percent of overlapping transcript changes within each mutant is
shown, along with associated p values. (B) qPCR validation of NeuroD6 and Gtse1mRNA
expression in indicated E11.5 mutant cortices. For RNA-seq and qPCR, each control was nor-
malized to 1.0 and compared to mutants. (C) Bar graph of top common enriched GO terms
identified with GSEA analysis among all 3 EJC mutants, showing corresponding fold enrich-
ment and P values. (D) Plot of all ribosomal protein transcripts for EJC mutant RNA seq. Stu-
dent’s t-test (B). Error bars, S.D, , p<0.05, , p<0.01, , p<0.001.
(TIF)
S3 Fig. GSEA analysis of transcriptome data of EJC mutants. (A, C, E) Enrichment plots
from GSEA KEGG analysis for Ribosome (A), Proteasome (C) and p53 signaling (E) terms. (B,
D, F) Venn diagrams of overlapping enriched genes between EJC mutants for the Ribosome
(B), Proteasome (D), and p53 signaling (F) terms. (G, H, I) STRING analysis of the genes
enriched in the Ribosome (G), Proteasome (H), and p53 signaling (I) pathways.
(TIF)
S4 Fig. GSEA analysis ofMagohMos2/+ transcriptome data. (A) Enrichment plots from GSEA
KEGG analysis for Ribosome, Proteasome, and p53 signaling terms. (B) Venn diagrams of
overlapping enriched genes between Emx1-Cre;Magohlox/+ andMagohMos2/+ mutants for the
Ribosome, Proteasome, and p53 signaling terms. (C) Top enriched GO terms from GSEA anal-
ysis ofMagohMos2/+ transcriptome. , p<0.001.
(TIF)
S5 Fig. Splicing Analysis ofMagoh, Rbm8a, and Eif4a3 haploinsufficient cortices. (A) Gel
image showing detection of increased Fus Ex6-8 RI events in E11.5MagohMos2/+mutants com-
pared to 2 litter mate controls. (B) STRING analysis including genes predicted to show identi-
cal, significant splicing changes in all 3 EJC mutants. Common genes that are not connected
with any other genes by STRING analysis were not included. Stronger associations are repre-
sented by thicker lines. Note two networks of splicing regulation (cyan) and Ribosome/Trans-
lation (orange).
(TIF)
S6 Fig. Proteomic Analysis of EJC mutants. (A) Venn diagrams of overlapping enriched pro-
teins altered between EJC mutants (p<0.05). (B) Bar graph depicting all ribosomal protein
changes relative to control showing similar trends in all 3 EJC mutants (control levels are set to 0).
(TIF)
S7 Fig. P53 rescue of EJC neurogenesis phenotypes. (A) Representative western blot for p53
in Emx1-Cre and Emx1-Cre;Rbm8alox/+ E11.5 dorsal cortex. (B-D) Immunostaining for CC3 in
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control (B), Emx1-Cre;Rbm8alox/+;p53lox/+ (C) and Emx1-Cre;Rbm8alox/+;p53lox/lox (D). (E-H)
Representative images of Satb2 immunostaining in E18.5 cortex from Emx1-Cre, Emx1-Cre;
Rbm8alox/+, Emx1-Cre;p53lox/lox and Emx1-Cre;Rbm8alox/+;p53lox/lox. (I) Quantification of
Satb2+ cells from E-H. ANOVA with Tukey posthoc. Error bars, S.D. ,p<0.05, ,p<0.01, ,
p<0.001, Scale bar, 50 μm.
(TIF)
S1 Table. Transcriptome analysis of EJC mutants.
(XLSX)
S2 Table. Transcriptome analysis GO terms.
(XLSX)
S3 Table. Splicing analysis of EJC mutants.
(XLSX)
S4 Table. Splicing analysis GO terms.
(XLSX)
S5 Table. Proteomic analysis of EJC mutants.
(XLSX)
S6 Table. Proteomic GO terms.
(XLSX)
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